NASDAQ: MDGLMadrigal Pharmaceuticals Inc Stock Ownership - Who owns Madrigal Pharmaceuticals?
Insider buying vs selling
Have Madrigal Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard S. Levy | Director | 2025-04-10 | 9,470 | $65.06 | $616.12kBuy |
| Fred B. Craves | Director | 2025-03-13 | 7,742 | $65.06 | $503.69kBuy |
| Fred B. Craves | Director | 2025-03-13 | 1,951 | $322.45 | $629.10kSell |
| Fred B. Craves | Director | 2025-03-13 | 1,649 | $323.47 | $533.39kSell |
| Fred B. Craves | Director | 2025-03-13 | 900 | $324.69 | $292.22kSell |
| Fred B. Craves | Director | 2025-03-13 | 800 | $325.63 | $260.50kSell |
| Fred B. Craves | Director | 2025-03-13 | 1,000 | $327.63 | $327.63kSell |
| Fred B. Craves | Director | 2025-03-13 | 400 | $328.68 | $131.47kSell |
| Fred B. Craves | Director | 2025-03-13 | 967 | $329.86 | $318.97kSell |
| Fred B. Craves | Director | 2025-03-13 | 75 | $330.23 | $24.77kSell |
MDGL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MDGL insiders and whales buy or sell their stock.
MDGL Shareholders
What type of owners hold Madrigal Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bruce Kovner | 103.88% | 22,937,805 | $7.82B | Insider |
| Cxsynta LLC | 35.15% | 7,761,716 | $2.65B | Insider |
| Lan Bo Chen | 27.82% | 6,142,288 | $2.09B | Insider |
| Fred B. Craves | 27.36% | 6,040,140 | $2.06B | Insider |
| Lin Huey Chen | 27.14% | 5,991,757 | $2.04B | Insider |
| Bay City Capital LLC | 26.03% | 5,747,267 | $1.96B | Insider |
| Safi R. Bahcall | 12.77% | 2,818,885 | $960.68M | Insider |
| Keith R. Gollust | 10.38% | 2,290,933 | $780.75M | Insider |
| Janus Henderson Group PLC | 10.00% | 2,208,394 | $752.62M | Institution |
| Paulson Co Inc | 9.25% | 2,042,000 | $695.91M | Institution |
MDGL vs Biotech Stocks
Madrigal Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.